- Cerrone Gabriele MDirector, 10% Owner$67.6K
- Mantelli FlavioChief Medical…$28K
- Dempsey Robert JohnChief Executive…$23.1K
- Brancaccio John PDirector$7.4K
- Patil Rajkumar V.Chief Scientific…$5K
Insider trading activity for OKYO Pharma Ltd, straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.
6 insiders bought on the open market within 30 days.
The 12 most recent Form 4 transactions.
How quickly insiders here report their trades. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
Everyone who has filed a Form 4 for this issuer.